Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 10, 2025

Integrative Genomic and Immune Profiling to Identify and Characterize High-Risk Subgroups in Acute Myeloid Leukemia: Development of a 20-Gene Predictive Signature and Its Clinical Implications.

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKubra KaragozMRM. Guy RoukensLCLizzy Comijn

Discussion

Loading...

Member takes

Overview

Integrative analysis shows a 20-gene signature predicts high-risk AML, suggesting personalized treatment strategies.

Key Points

  • The developed 20-gene signature accurately predicts high-risk AML subgroups, enhancing treatment personalization.
  • Using nonnegative matrix factorization on RNA sequencing data from 462 patients, the study identified key genomics of risk subtypes.
  • Immune profiling revealed an immunosuppressive tumor microenvironment characterized by increased M2 macrophages.
  • Findings indicate that high-risk AML cell lines are less sensitive to standard therapy but responsive to targeted MAPK and PI3K inhibitors.

Cite This Study

Karagoz et al. (2025) studied this question.

synapsesocial.com/papers/68c23b8fb210217d647855f5https://doi.org/10.1177/15578100251370570
View Full Paper
Ask AI
Bookmark
Share